01 Apr 2025
Hormone Replacement Therapy (HRT) Patch Shortages: PBS Subsidy Updates & Substitution Options for Estradot, Estraderm MX, and Overseas Alternatives
Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives
01 Apr 2025
1 April 2025 designated brand list – minimum stockholding requirements
1 April 2025 designated brand list – minimum stockholding requirements
21 Mar 2025
Drug Utilization Sub-Committee (DUSC) Summary Statement
Drug Utilisation Sub-Committee (DUSC) Outcome Statement
21 Mar 2025
PBAC Public Summary Documents (first time decisions not to recommend and deferrals)– November 2024 meeting
PBAC Public Summary Documents (first time decisions not to recommend and deferrals)– November 2024 meeting
14 Mar 2025
Public Release Documents for Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis
Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents
12 Mar 2025
New Minimum Stockholding Requirement Fact Sheets and Updated Web Content
New Minimum Stockholding Requirement Fact Sheets and Updated Web Content
07 Mar 2025
PBAC Public Summary Documents – November 2024 meeting
PBAC Public Summary Documents – November 2024 meeting
05 Mar 2025
"Revised Provisions for Continued Dispensing During Emergencies"
Update to Continued Dispensing Arrangements – Emergency Measures
04 Mar 2025
Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives -4 March 2025
Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives
